Cargando…
Measuring quality of gout management in residential aged care facilities
OBJECTIVE: Gout, a common form of arthritis, can be controlled successfully with pharmacotherapy and is thus an ideal model for examining chronic disease management. Our aim was to examine treatment of gout evaluated in accordance with general management guidelines for gout as applied to Australian...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710438/ https://www.ncbi.nlm.nih.gov/pubmed/36465481 http://dx.doi.org/10.1093/rap/rkac091 |
_version_ | 1784841366485860352 |
---|---|
author | Nguyen, Amy D Lind, Kimberly E Day, Richard O Ross, Daniel Raban, Magdalena Z Georgiou, Andrew Westbrook, Johanna I |
author_facet | Nguyen, Amy D Lind, Kimberly E Day, Richard O Ross, Daniel Raban, Magdalena Z Georgiou, Andrew Westbrook, Johanna I |
author_sort | Nguyen, Amy D |
collection | PubMed |
description | OBJECTIVE: Gout, a common form of arthritis, can be controlled successfully with pharmacotherapy and is thus an ideal model for examining chronic disease management. Our aim was to examine treatment of gout evaluated in accordance with general management guidelines for gout as applied to Australian residential aged care facilities. METHODS: Electronic health record data linked with aged care clinical notes and electronic medication administration information (11 548 residents in 68 residential aged care facilities, >65 years of age) were interrogated to identify people with gout, other chronic conditions and gout medication use. The outcomes examined were the proportion receiving urate-lowering therapy (ULT; preventative medication) and/or colchicine/non-steroidal anti-inflammatory drug (NSAID) (to treat gout flares), the number of ULT and colchicine/NSAID treatment episodes (periods of continuous days of medication use) and the duration of these treatment episodes. RESULTS: The cohort included 1179 residents with gout, of whom 62% used a ULT, with a median of one episode of use for a very short duration [median = 4 days, median of use in total (i.e. repeated use) = 52 days]. Among residents with gout, 9% also used colchicine or an NSAID. Female residents were less likely to receive ULT and for shorter periods. CONCLUSION: Nearly one-third of residents with gout did not receive ULT. In those receiving ULT, recurrent short courses were common. Overall, management of gout in aged care residents appears to be suboptimal, largely owing to intermittent and short exposure to ULT, and with female residents at greater risk of poor gout management. |
format | Online Article Text |
id | pubmed-9710438 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-97104382022-12-01 Measuring quality of gout management in residential aged care facilities Nguyen, Amy D Lind, Kimberly E Day, Richard O Ross, Daniel Raban, Magdalena Z Georgiou, Andrew Westbrook, Johanna I Rheumatol Adv Pract Original Article OBJECTIVE: Gout, a common form of arthritis, can be controlled successfully with pharmacotherapy and is thus an ideal model for examining chronic disease management. Our aim was to examine treatment of gout evaluated in accordance with general management guidelines for gout as applied to Australian residential aged care facilities. METHODS: Electronic health record data linked with aged care clinical notes and electronic medication administration information (11 548 residents in 68 residential aged care facilities, >65 years of age) were interrogated to identify people with gout, other chronic conditions and gout medication use. The outcomes examined were the proportion receiving urate-lowering therapy (ULT; preventative medication) and/or colchicine/non-steroidal anti-inflammatory drug (NSAID) (to treat gout flares), the number of ULT and colchicine/NSAID treatment episodes (periods of continuous days of medication use) and the duration of these treatment episodes. RESULTS: The cohort included 1179 residents with gout, of whom 62% used a ULT, with a median of one episode of use for a very short duration [median = 4 days, median of use in total (i.e. repeated use) = 52 days]. Among residents with gout, 9% also used colchicine or an NSAID. Female residents were less likely to receive ULT and for shorter periods. CONCLUSION: Nearly one-third of residents with gout did not receive ULT. In those receiving ULT, recurrent short courses were common. Overall, management of gout in aged care residents appears to be suboptimal, largely owing to intermittent and short exposure to ULT, and with female residents at greater risk of poor gout management. Oxford University Press 2022-11-28 /pmc/articles/PMC9710438/ /pubmed/36465481 http://dx.doi.org/10.1093/rap/rkac091 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Nguyen, Amy D Lind, Kimberly E Day, Richard O Ross, Daniel Raban, Magdalena Z Georgiou, Andrew Westbrook, Johanna I Measuring quality of gout management in residential aged care facilities |
title | Measuring quality of gout management in residential aged care facilities |
title_full | Measuring quality of gout management in residential aged care facilities |
title_fullStr | Measuring quality of gout management in residential aged care facilities |
title_full_unstemmed | Measuring quality of gout management in residential aged care facilities |
title_short | Measuring quality of gout management in residential aged care facilities |
title_sort | measuring quality of gout management in residential aged care facilities |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710438/ https://www.ncbi.nlm.nih.gov/pubmed/36465481 http://dx.doi.org/10.1093/rap/rkac091 |
work_keys_str_mv | AT nguyenamyd measuringqualityofgoutmanagementinresidentialagedcarefacilities AT lindkimberlye measuringqualityofgoutmanagementinresidentialagedcarefacilities AT dayrichardo measuringqualityofgoutmanagementinresidentialagedcarefacilities AT rossdaniel measuringqualityofgoutmanagementinresidentialagedcarefacilities AT rabanmagdalenaz measuringqualityofgoutmanagementinresidentialagedcarefacilities AT georgiouandrew measuringqualityofgoutmanagementinresidentialagedcarefacilities AT westbrookjohannai measuringqualityofgoutmanagementinresidentialagedcarefacilities |